Mediclinic International plc Financials

Market Capitalization R88.13 Billion as of May 1, 2023

Valuations Metrics as of Jan. 25, 2025

Trailing PE	21.09
Forward PE
Price to Sales TTM	R26.05
Price to Book MRQ	R2461.51
Enterprise to Revenue	26.54
Enterprise to EBITDA	212.22

Financial Reports as of Sep. 30, 2022

Financials

Fiscal Year Ends	2022-03-31
Most Recent Quarter	2022-09-30
Profit Margin	5.00%
Operating Margin	8.10%
Return on Assets TTM	2.30%
Return on Equity TTM	5.50%

Income Statement

Revenue TTM	R3,233,000,000
Revenue per Share TTM	R4.59
Quarterly Revenue Growth	9.50%
Gross Profit TTM	R505,000,000
EBITDA	R515,000,000
Net Income to Common TTM	R151,000,000
Diluted EPS TTM	R5.61
Quarterly Earnings Growth YoY	27.70%

Balance Sheet

Total Cash MRQ	RNone
Total Cash per Share MRQ	R0.62
Total Debt MRQ	R
Total Debt to Equity MRQ	78.38
Current Ratio MRQ	1.49
Book Value per Share MRQ	R4.81

Cash Flow

Operating Cash Flow TTM	R328,000,000
Levered Free Cash Flow TTM	R151,000,000

MEI Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	737,244,032
Float Shares	340,672,992
Avg 10 Volume	1,677,332
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	48.87%
% Held by Institutions	39.20%

Stock Price Summary

Beta	0.42
Fifty Two Week Low	R8312.00
Fifty Two Week High	R12092.00
Fifty Two Week Change	38.39%
Day 50 MA	R11388.44
Day 200 MA	R10542.41

Dividends and Splits

Forward Annual Dividend Rate	R238.13
Forward Annual Dividend Yield	2.01%
Trailing Annual Dividend Rate	R59.53
Trailing Annual Dividend Yield	0.50%
Payout Ratio	12.84%
Dividend Date
Ex Dividend Date	2022-08-03
Last Split Factor
Last Split Date